Inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy

Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also found evidence of how it may be possible to protect young leukemia patients without jeopardizing cures. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *